Peter Heerma

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

TVTX

Current role

2 calls Latest call 2026-08-04

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Travere Therapeutics, Inc. (TVTX)	Chief Commercial Officer	$527,917	—	$583,110	$738,247	$397,500	$14,977	$2,261,751
2024	Travere Therapeutics, Inc. (TVTX)	Chief Commercial Officer	$503,750	—	$299,155	$342,258	$353,500	$14,697	$1,513,360
2023	Travere Therapeutics, Inc. (TVTX)	Chief Commercial Officer	$487,167	—	$604,800	$656,747	$240,100	$15,100	$2,003,914
2022	Travere Therapeutics, Inc. (TVTX)	Chief Commercial Officer	$453,190	—	$761,200	$538,929	$239,400	$13,028	$2,005,747
2021	Travere Therapeutics, Inc. (TVTX)	Chief Commercial Officer	$421,685	—	$403,200	$791,194	$253,368	$11,529	$1,880,976
2020	Travere Therapeutics, Inc. (TVTX)	Chief Commercial Officer	$407,667	$87,500	$278,280	$508,217	$232,050	$18,576	$1,532,290
2019	Travere Therapeutics, Inc. (TVTX)	Chief Commercial Officer	$100,000	$87,500	$393,750	$695,130	$46,250	$2,648	$1,325,278

Earnings-call appearances and filed executive appointments or departures, newest first.